The debate behind Xi’s Stabilizer Pitch Should Not Buy Him Chip Relief

Advocate A’s weakest point is the inference that China can monetize “stabilizer” status across Iran, Taiwan, and trade. That framing confuses two different things: China’s ability to issue de-escalatory statements and China’s ability to deliver outcomes that reduce U.S. risk more than Chinese risk. On Iran/Hormuz, China is not an outside guarantor with low exposure; it is one of the most exposed large economies. EIA data show China, India, Japan, and South Korea were the top destinations for crude moving through Hormuz to Asia, together taking 69% of Hormuz crude and condensate flows in 2024, while the United States’ Hormuz-linked crude imports were only about 2% of U.S. petroleum liquids consumption. That means China’s call to reopen Hormuz is partly self-protection, not a scarce concession Trump must buy with chip or tariff relief. On Taiwan, the same logic is sharper: Beijing cannot credibly sell “stability” for refraining from pressure it itself generates. A de-escalation offer has value, but it is not equivalent to leverage unless Xi can show verifiable, durable restraint.

A also overstates the practical collapse of Trump’s tariff leverage. The Court of International Trade ruling on the 10% global tariff matters, but Axios’s own account says collections continue during appeal and notes a “plan C” through Section 301 investigations. Separately, legal summaries of the February Supreme Court IEEPA decision emphasize that other second-term tariff authorities remained intact, including Section 232 measures and China-related Section 301 tariffs. So the bargaining baseline is not “Trump has no credible tariffs”; it is “some emergency-law tariffs are legally weaker, while narrower trade-law tools remain available.” That favors using any truce to lock Chinese commitments, not preemptively paying Beijing for a pause.

The stronger structural evidence runs against Xi. First, China’s economy needs external demand because domestic demand remains weak. The IMF’s 2026 Article IV projected China’s growth slowing to 4.5% in 2026 and specifically linked the outlook to tariffs and trade-policy uncertainty, while noting low inflation and real depreciation had supported exports and lifted the current account. PwC’s China Economic Quarterly reported a record 2025 trade surplus of about $1.19 trillion. That is not a position from which Beijing can casually absorb renewed trade shocks.

Second, high-end chip controls still bite. BIS’s December 2024 package targeted China’s ability to produce advanced-node semiconductors for AI and advanced computing, adding controls on semiconductor manufacturing equipment, software tools, high-bandwidth memory, and 140 Entity List entries. If Beijing wants relief, that confirms U.S. leverage; it does not prove Washington should trade away controls without measurable concessions.

Third, the U.S. market remains material. USTR reports $414.7 billion in U.S.-China goods trade in 2025 and a $202.1 billion U.S. goods deficit with China. A tariff truce is valuable to both sides, but China’s export-led cushion makes it especially valuable to Xi. The correct negotiating posture is therefore conditional de-escalation: tariff relief only for enforceable Chinese commitments on market access, rare-earth reliability, fentanyl precursors, export-control circumvention, and Taiwan-risk reduction.

A’s rebuttal concedes the central weakness: China’s “stabilizer” offer is not an exogenous service but a mix of self-protection and restraint from risks Beijing or its partners help generate. A admits China is heavily exposed to Hormuz, that Trump’s tariff powers are not exhausted, and that China wants some relief from export-control pressure. Those concessions imply that Xi is not bargaining from superior freedom of action. He is bargaining to prevent shocks that would damage China’s own economy and to obtain relief from U.S. tools that still matter.

The Hormuz point is decisive because A tries to convert a U.S. request for Chinese help into Chinese leverage. But EIA data show the direct energy vulnerability runs far more through Asia: China, India, Japan, and South Korea received 69% of Hormuz crude and condensate flows in 2024, while U.S. imports through Hormuz equaled about 2% of U.S. petroleum liquids consumption. AP’s reporting that Rubio said China was being hit harder reinforces B’s point, not A’s: if Beijing is pressed to help reopen the strait, it is being asked to act in its own economic interest, not to provide a costly concession that deserves payment in chips or tariffs. (eia.gov)

A’s tariff-law answer also narrows into a timing argument, not a leverage argument. Yes, universal emergency tariffs are legally impaired. But Axios reported the administration was already looking to Section 301 investigations as “plan C,” and legal analyses of the February Supreme Court ruling state that Section 232 and Section 301 tariffs remained intact. That means China cannot rationally assume Trump is out of coercive tools; it can only hope broader tools are slower or more litigated. Slower leverage is not no leverage, especially when a summit truce can be conditioned on Chinese commitments. (axios.com)

A’s biggest concession is that Xi’s ask is “limited.” That is effectively B’s position: if Beijing can only seek implementation relief, licensing flexibility, or delayed snapbacks, then Trump should trade only for verifiable concessions. The 2025 Affiliates Rule precedent proves conditional exchange, not unilateral reward: BIS paused the rule for one year while China paused rare-earth measures. That structure supports snapbacks and compliance benchmarks, not paying Beijing merely for lowering a temperature it can raise again. (jonesday.com)

Finally, A underweights China’s structural need for de-escalation. The IMF projected Chinese growth slowing to 4.5% in 2026 because of tariffs and trade-policy uncertainty and warned weak domestic demand could entrench deflationary pressure. USTR reports U.S.-China goods trade still totaled $414.7 billion in 2025, and BIS’s December 2024 package targeted advanced-node semiconductor production, HBM, software tools, and 140 entities. The core issue is whether Xi can extract concessions without making real concessions. A shows Xi can create or reduce risk; B shows China needs the truce and chip relief enough that Trump should demand enforceable commitments before giving anything durable. (imf.org)

A’s strongest argument is that leverage at a summit is marginal, not structural: even if China is vulnerable, Trump faces a tighter immediate clock because oil risk, financial-market sensitivity, legal pressure on universal tariffs, Taiwan escalation, and summit optics all converge before May 14–15. A can fairly say that China does not need to be a benevolent stabilizer to extract value; if Washington publicly wants Chinese help on Hormuz and a cooler Taiwan/trade environment, Xi can trade partial de-escalation for limited tariff or export-control relief. A is also right that the 2025 Affiliates Rule/rare-earth pause shows some export-control implementation issues have already been negotiated.

My position is still stronger because A’s case converts U.S. desire for risk reduction into Chinese bargaining dominance without showing that China can withhold that risk reduction at lower cost than the United States can withhold tariff and technology relief. The Hormuz evidence cuts against A’s inference: EIA reports that China, India, Japan, and South Korea took 69% of Hormuz crude and condensate flows in 2024, while U.S. Hormuz-linked crude imports equaled about 2% of U.S. petroleum liquids consumption. A global oil spike matters politically in the United States, but China’s direct energy and manufacturing exposure makes reopening Hormuz a Chinese necessity, not a concession Washington should buy with high-value technology relief.

The tariff-law issue is also narrower than A needs. Axios reported that the trade-court ruling against Trump’s 10% universal tariff left collections continuing during appeal and that Section 301 investigations were already identified as a fallback. That means Trump’s broadest instrument is impaired, but China still faces credible, China-specific trade-law escalation. The right negotiating lesson is not “pay Xi for a truce”; it is “use the truce to obtain measurable commitments before extending relief.”

The structural data make that posture more compelling. The IMF projected China’s 2026 growth slowing to 4.5%, tied in part to tariffs and trade-policy uncertainty, and warned that weak domestic demand could entrench deflationary pressure while exports may contribute less going forward. USTR still reports $414.7 billion in U.S.-China goods trade in 2025 and a $202.1 billion U.S. goods deficit, confirming that access to external demand remains material. Meanwhile, BIS’s December 2024 controls targeted advanced-node semiconductor production, HBM, software tools, and 140 entities; if Beijing seeks relief, that proves U.S. leverage remains salient.

So A has shown that Xi can ask for limited relief. B’s stronger claim is that Trump should grant only conditional, snapback-backed relief because China’s slowing economy, export dependence, energy exposure, and chip vulnerability make Chinese concessions necessary for any durable truce.